4/A//SEC Filing
CHIANG MING-FU (ALAN) 4/A
Accession 0001213900-25-051691
CIK 0001979414other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 7:25 PM ET
Size
18.6 KB
Accession
0001213900-25-051691
Insider Transaction Report
Form 4/AAmended
CHIANG MING-FU (ALAN)
Director
Transactions
- Other
Common Stock
2025-03-26−5,994→ 324,688 total(indirect: By LLC) - Exercise of In-Money
Common Stock
2025-03-26$12.00/sh+117,188$1,406,256→ 441,876 total(indirect: By LLC) - Sale
Common Stock
2025-03-26$19.13/sh−1,446$27,662→ 384,180 total(indirect: By LLC) - Exercise of In-Money
Warrant (right to buy)
2025-03-26−117,188→ 0 total(indirect: By LLC)Exercise: $12.00From: 2025-03-26→ Common Stock (117,188 underlying) - Award
Common Stock
2025-03-26+50,000→ 390,216 total - Sale
Common Stock
2025-03-26$25.00/sh−56,250$1,406,250→ 385,626 total(indirect: By LLC)
Holdings
- 888,148(indirect: By NeuCen Biomedical Co. Ltd.)
Common Stock
- 488,196(indirect: See footnote 9.)
Common Stock
- 29,309(indirect: By Orion Biomed Inc.)
Common Stock
Footnotes (10)
- [F1]Grant of 50,000 shares of restricted common stock (the "Shares") pursuant to Issuer's 2023 Equity Incentive Plan. The Shares vest 100% seven months after the effective date of Issuer's initial listing.
- [F10]Not applicable.
- [F2]Transfer of shares of common stock held by HCWG LLC ("HCWG") pursuant to agreement. The shares reported herein represent only Reporting Person's percentage interest in HCWG LLC. See also footnote 4.
- [F3]Not applicable. Number of shares transferred was based on a per share value of $18.
- [F4]Such shares are held by virtue of beneficial ownership of HCWG. The shares represent only Reporting Person's 37.5% interest in HCWG.
- [F5]On 3/26/2025, in conjunction with Issuer's initial listing on Nasdaq, HCWG exercised a warrant to purchase 312,500 shares of Issuer's common stock at $12 per share. HCWG paid the exercise price on a cashless basis, resulting in Issuer's withholding 150,000 of the warrant shares to pay the exercise price and issuing to HCWG the remaining 162,500 shares of common stock. Number of shares reported herein as acquired and disposed of by the Reporting Person represents Reporting Person's indirect interest in HCWG.
- [F6]In connection with HCWG's cashless exercise of the warrant described herein, Reporting Person paid his proportionate share of the exercise price on a cashless basis. Reporting Person's proportionate withholding from shares issued to HCWG totaled 56,250 warrant shares to pay the exercise price.
- [F7]Shares held by Orion Biotech Inc. ("Orion"). Orion is owned in part by Reporting Person, who disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- [F8]Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
- [F9]Shares held by certain members of Reporting Person's family. Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.
Documents
Issuer
NEONC TECHNOLOGIES HOLDINGS, INC.
CIK 0001979414
Entity typeother
Related Parties
1- filerCIK 0002055126
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 7:25 PM ET
- Size
- 18.6 KB